Overview Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis Status: Recruiting Trial end date: 2022-10-31 Target enrollment: Participant gender: Summary The aim of the investigators study was to investigate the safety and efficacy of allogeneic ADSCs for the clinical treatment of knee osteoarthritis. Phase: Phase 1/Phase 2 Details Lead Sponsor: Gwo Xi Stem Cell Applied Technology Co., Ltd.